Adipogen/Orlistat/AG-CN2-0050-M250/250 mg-免疫在线蚂蚁淘旗下平台-

当前位置：首页 > 新闻动态 >

热卖商品

列出<em>C的SNAPtide®520底物的生物/非猝灭校准肽。肉毒杆菌</em>A型神经毒素/529/50

列出C的SNAPtide®520底物的生物/非猝灭校准肽。肉毒杆菌A型神经毒素/529/50

列出生物/抗志贺样毒素2（小鼠IgG1-κ）/764/100微克

List Biological/Exotoxin A from <em>Pseudomonas aeruginosa</em>/160/1 mg

List Biological/Exotoxin A from Pseudomonas aeruginosa/160/1 mg

列出SNAPtide®521的<em>C的生物/对照肽。肉毒杆菌</em>A型神经毒素/526/200毫摩尔

列出SNAPtide®521的C的生物/对照肽。肉毒杆菌A型神经毒素/526/200毫摩尔

新闻详情

Adipogen/Orlistat/AG-CN2-0050-M250/250 mg

来自 : 发布时间：2025-01-15

More Information Product Details Synonyms Product Type Properties Formula MW Merck Index CAS Source/Host Chemicals Purity Chemicals Appearance Solubility Identity InChi Key Shipping and Handling Shipping Short Term Storage Long Term Storage Handling Advice Use/Stability Documents MSDS Product Specification Sheet Datasheet

Tetrahydrolipstatin; Xenical; Alli; Ro-18-0647

Chemical

C₂₉H₅₃NO₅

495.7

14: 6869

96829-58-2

Synthetic. Originally isolated from Streptomyces sp.

≥98% (HPLC)

White to off-white solid.

Soluble in DMSO, ethanol or DMF.

Determined by HPLC and IR.

AHLBNYSZXLDEJQ-FWEHEUNISA-N

AMBIENT

+4°C

-20°C

After reconstitution, prepare aliquots and store at -20°C.Protect from light and moisture.

Stable for at least 2 years after receipt when stored at -20°C.

Download PDF

Hypolipemic cell permeable and irreversible pancreatic, gastric and carboxylester lipase inhibitor [1-3].
Anti-obesity and antihypercholesterolemic compound [2, 5, 11].
Antitumor compound by inhibition of the thioesterase domain of fatty acid synthase (FASN) [4, 6, 9, 10].
Anti-proliferative [4, 6, 9, 10].
Causes cell cycle arrest at G1 phase. Apoptosis inducer through caspase-3 activation [6, 10].
Sn-1-selective-diacylglycerol lipases α (DAGLα) inhibitor. Targets serine hydrolases in the nervous system, such as diacylglycerol lipase (DAGL), which is responsible for the conversion of DAG to 2-AG [7].
Partially inhibits the hydrolysis of triglycerides and lowers the absorption of dietary fat, promoting weight loss [8].
Promotes the sensitivity to TRAIL in cancer cells by ROS-mediated pathways [11].

Product References

Interactions of lipoprotein lipase with the active-site inhibitor tetrahydrolipstatin (Orlistat): A. Lookene, et al.; Eur. J. Biochem. 222, 395 (1994)

Mode of action of orlistat: R. Guerciolini; Int. J Obes. Relat. Metab. Disord. 2, S12 (1997) (Review)

Degree of in vivo inhibition of human gastric and pancreatic lipases by Orlistat (Tetrahydrolipstatin, THL) in the stomach and small intestine: B. Sternby, et al.; Clin. Nutr. 21, 395 (2002)

Orlistat is a novel inhibitor of fatty acid synthase with antitumor activity: S.J. Kridel, et al.; Cancer Res. 64, 2070 (2004)

The use of orlistat in the treatment of obesity, dyslipidaemia and Type 2 diabetes: R.H. Nelson & J.M. Miles; Expert Opin. Pharmacother. 6, 2483 (2005) (Review)

Antitumoral actions of the anti-obesity drug orlistat (XenicalTM) in breast cancer cells: blockade of cell cycle progression, promotion of apoptotic cell death and PEA3-mediated transcriptional repression of Her2/neu (erbB-2) oncogene: J.A. Menendez, et al.; Ann. Oncol. 16, 1253 (2005)

Development of the first potent and specific inhibitors of endocannabinoid biosynthesis: T. Bisogno, et al.; Biochim. Biophys. Acta 1761, 205 (2006)

Orlistat accelerates gastric emptying and attenuates GIP release in healthy subjects: F.Y. Enc, et al.; Am. J. Physiol. Gastrointest. Liver Physiol. 296, G482 (2008)

Fatty acid synthase inhibition with Orlistat promotes apoptosis and reduces cell growth and lymph node metastasis in a mouse melanoma model: M.A. Carvalho, et al.; Int. J. Cancer. 123, 2557 (2008)

Antitumor effect of orlistat, a fatty acid synthase inhibitor, is via activation of caspase-3 on human colorectal carcinoma-bearing animal: H.Y. Chuang, et al.; Biomed. Pharmacother. 65, 286 (2011)

The anti-obesity drug orlistat promotes sensitivity to TRAIL by two different pathways in hormone-refractory prostate cancer cells: J. Fujiwara, et al.; Int. J. Oncol. 48, 854 (2016)

本文链接： http://list.immuno-online.com/view-1523062121.html

发布于： 2025-01-15 阅读（）

没有了